United States Drug-Eluting Bioabsorbable Stents Market Report 2018

United States Drug-Eluting Bioabsorbable Stents Market Report 2018

1 Drug-Eluting Bioabsorbable Stents Overview

1.1 Product Overview and Scope of Drug-Eluting Bioabsorbable Stents

1.2 Classification of Drug-Eluting Bioabsorbable Stents by Product Category

1.2.1 United States Drug-Eluting Bioabsorbable Stents Market Size (Sales Volume) Comparison by Type (2013-2025)

1.2.2 United States Drug-Eluting Bioabsorbable Stents Market Size (Sales Volume) Market Share by Type (Product Category) in 2017

1.2.3 Serolimus and Paclitaxel Drug-Eluting Stents

1.2.4 Sirolimus Drug Eluting Stents

1.3 United States Drug-Eluting Bioabsorbable Stents Market by Application/End Users

1.3.1 United States Drug-Eluting Bioabsorbable Stents Market Size (Consumption) and Market Share Comparison by Application (2013-2025)

1.3.2 Coronary Artery Diseases

1.3.3 Peripheral Artery Diseases

1.4 United States Drug-Eluting Bioabsorbable Stents Market by Region

1.4.1 United States Drug-Eluting Bioabsorbable Stents Market Size (Value) Comparison by Region (2013-2025)

1.4.2 The West Drug-Eluting Bioabsorbable Stents Status and Prospect (2013-2025)

1.4.3 Southwest Drug-Eluting Bioabsorbable Stents Status and Prospect (2013-2025)

1.4.4 The Middle Atlantic Drug-Eluting Bioabsorbable Stents Status and Prospect (2013-2025)

1.4.5 New England Drug-Eluting Bioabsorbable Stents Status and Prospect (2013-2025)

1.4.6 The South Drug-Eluting Bioabsorbable Stents Status and Prospect (2013-2025)

1.4.7 The Midwest Drug-Eluting Bioabsorbable Stents Status and Prospect (2013-2025)

1.5 United States Market Size (Value and Volume) of Drug-Eluting Bioabsorbable Stents (2013-2025)

1.5.1 United States Drug-Eluting Bioabsorbable Stents Sales and Growth Rate (2013-2025)

1.5.2 United States Drug-Eluting Bioabsorbable Stents Revenue and Growth Rate (2013-2025)

2 United States Drug-Eluting Bioabsorbable Stents Market Competition by Players/Suppliers

2.1 United States Drug-Eluting Bioabsorbable Stents Sales and Market Share of Key Players/Suppliers (2013-2018)

2.2 United States Drug-Eluting Bioabsorbable Stents Revenue and Share by Players/Suppliers (2013-2018)

2.3 United States Drug-Eluting Bioabsorbable Stents Average Price by Players/Suppliers (2013-2018)

2.4 United States Drug-Eluting Bioabsorbable Stents Market Competitive Situation and Trends

2.4.1 United States Drug-Eluting Bioabsorbable Stents Market Concentration Rate

2.4.2 United States Drug-Eluting Bioabsorbable Stents Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Drug-Eluting Bioabsorbable Stents Manufacturing Base Distribution, Sales Area, Product Type

3 United States Drug-Eluting Bioabsorbable Stents Sales (Volume) and Revenue (Value) by Region (2013-2018)

3.1 United States Drug-Eluting Bioabsorbable Stents Sales and Market Share by Region (2013-2018)

3.2 United States Drug-Eluting Bioabsorbable Stents Revenue and Market Share by Region (2013-2018)

3.3 United States Drug-Eluting Bioabsorbable Stents Price by Region (2013-2018)

4 United States Drug-Eluting Bioabsorbable Stents Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)

4.1 United States Drug-Eluting Bioabsorbable Stents Sales and Market Share by Type (Product Category) (2013-2018)

4.2 United States Drug-Eluting Bioabsorbable Stents Revenue and Market Share by Type (2013-2018)

4.3 United States Drug-Eluting Bioabsorbable Stents Price by Type (2013-2018)

4.4 United States Drug-Eluting Bioabsorbable Stents Sales Growth Rate by Type (2013-2018)

5 United States Drug-Eluting Bioabsorbable Stents Sales (Volume) by Application (2013-2018)

5.1 United States Drug-Eluting Bioabsorbable Stents Sales and Market Share by Application (2013-2018)

5.2 United States Drug-Eluting Bioabsorbable Stents Sales Growth Rate by Application (2013-2018)

5.3 Market Drivers and Opportunities

6 United States Drug-Eluting Bioabsorbable Stents Players/Suppliers Profiles and Sales Data

6.1 Medtronic

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Drug-Eluting Bioabsorbable Stents Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Medtronic Drug-Eluting Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2013-2018)

6.1.4 Main Business/Business Overview

6.2 B.Braun Melsungen

6.2.2 Drug-Eluting Bioabsorbable Stents Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2013-2018)

6.2.4 Main Business/Business Overview

6.3 Abbott Laboratories

6.3.2 Drug-Eluting Bioabsorbable Stents Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2013-2018)

6.3.4 Main Business/Business Overview

6.4 Boston Scientific Corporation

6.4.2 Drug-Eluting Bioabsorbable Stents Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2013-2018)

6.4.4 Main Business/Business Overview

6.5 Biosensors International

6.5.2 Drug-Eluting Bioabsorbable Stents Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Biosensors International Drug-Eluting Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2013-2018)

6.5.4 Main Business/Business Overview

6.6 Terumo Corporation.

6.6.2 Drug-Eluting Bioabsorbable Stents Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2013-2018)

6.6.4 Main Business/Business Overview

6.7 MicroPort Scientific Corporation

6.7.2 Drug-Eluting Bioabsorbable Stents Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2013-2018)

6.7.4 Main Business/Business Overview

6.8 Alvimedica

6.8.2 Drug-Eluting Bioabsorbable Stents Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Alvimedica Drug-Eluting Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2013-2018)

6.8.4 Main Business/Business Overview

6.9 Biotronik

6.9.2 Drug-Eluting Bioabsorbable Stents Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Biotronik Drug-Eluting Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2013-2018)

6.9.4 Main Business/Business Overview

6.10 Elixir Medical Corporation

6.10.2 Drug-Eluting Bioabsorbable Stents Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Sales, Revenue, Price and Gross Margin (2013-2018)

6.10.4 Main Business/Business Overview

6.11 Innovative Health Technologies

7 Drug-Eluting Bioabsorbable Stents Manufacturing Cost Analysis

7.1 Drug-Eluting Bioabsorbable Stents Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Drug-Eluting Bioabsorbable Stents

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Drug-Eluting Bioabsorbable Stents Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Drug-Eluting Bioabsorbable Stents Major Manufacturers in 2017

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Drug-Eluting Bioabsorbable Stents Market Size (Value and Volume) Forecast (2018-2025)

11.1 United States Drug-Eluting Bioabsorbable Stents Sales Volume, Revenue Forecast (2018-2025)

11.2 United States Drug-Eluting Bioabsorbable Stents Sales Volume Forecast by Type (2018-2025)

11.3 United States Drug-Eluting Bioabsorbable Stents Sales Volume Forecast by Application (2018-2025)

11.4 United States Drug-Eluting Bioabsorbable Stents Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Drug-Eluting Bioabsorbable Stents

Figure United States Drug-Eluting Bioabsorbable Stents Market Size (K Units) by Type (2013-2025)

Figure United States Drug-Eluting Bioabsorbable Stents Sales Volume Market Share by Type (Product Category) in 2017

Figure Serolimus and Paclitaxel Drug-Eluting Stents Product Picture

Figure Sirolimus Drug Eluting Stents Product Picture

Figure United States Drug-Eluting Bioabsorbable Stents Market Size (K Units) by Application (2013-2025)

Figure United States Sales Market Share of Drug-Eluting Bioabsorbable Stents by Application in 2017

Figure Coronary Artery Diseases Examples

Table Key Downstream Customer in Coronary Artery Diseases

Figure Peripheral Artery Diseases Examples

Table Key Downstream Customer in Peripheral Artery Diseases

Figure United States Drug-Eluting Bioabsorbable Stents Market Size (Million USD) by Region (2013-2025)

Figure The West Drug-Eluting Bioabsorbable Stents Revenue (Million USD) and Growth Rate (2013-2025)

Figure Southwest Drug-Eluting Bioabsorbable Stents Revenue (Million USD) and Growth Rate (2013-2025)

Figure The Middle Atlantic Drug-Eluting Bioabsorbable Stents Revenue (Million USD) and Growth Rate (2013-2025)

Figure New England Drug-Eluting Bioabsorbable Stents Revenue (Million USD) and Growth Rate (2013-2025)

Figure The South of US Drug-Eluting Bioabsorbable Stents Revenue (Million USD) and Growth Rate (2013-2025)

Figure The Midwest Drug-Eluting Bioabsorbable Stents Revenue (Million USD) and Growth Rate (2013-2025)

Figure United States Drug-Eluting Bioabsorbable Stents Sales (K Units) and Growth Rate (2013-2025)

Figure United States Drug-Eluting Bioabsorbable Stents Revenue (Million USD) and Growth Rate (2013-2025)

Figure United States Drug-Eluting Bioabsorbable Stents Market Major Players Product Sales Volume (K Units) (2013-2018)

Table United States Drug-Eluting Bioabsorbable Stents Sales (K Units) of Key Players/Suppliers (2013-2018)

Table United States Drug-Eluting Bioabsorbable Stents Sales Share by Players/Suppliers (2013-2018)

Figure 2017 United States Drug-Eluting Bioabsorbable Stents Sales Share by Players/Suppliers

Figure 2017 United States Drug-Eluting Bioabsorbable Stents Sales Share by Players/Suppliers

Figure United States Drug-Eluting Bioabsorbable Stents Market Major Players Product Revenue (Million USD) (2013-2018)

Table United States Drug-Eluting Bioabsorbable Stents Revenue (Million USD) by Players/Suppliers (2013-2018)

Table United States Drug-Eluting Bioabsorbable Stents Revenue Share by Players/Suppliers (2013-2018)

Figure 2017 United States Drug-Eluting Bioabsorbable Stents Revenue Share by Players/Suppliers

Figure 2017 United States Drug-Eluting Bioabsorbable Stents Revenue Share by Players/Suppliers

Table United States Market Drug-Eluting Bioabsorbable Stents Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)

Figure United States Market Drug-Eluting Bioabsorbable Stents Average Price (USD/Unit) of Key Players/Suppliers in 2017

Figure United States Drug-Eluting Bioabsorbable Stents Market Share of Top 3 Players/Suppliers

Figure United States Drug-Eluting Bioabsorbable Stents Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Drug-Eluting Bioabsorbable Stents Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Drug-Eluting Bioabsorbable Stents Product Category

Table United States Drug-Eluting Bioabsorbable Stents Sales (K Units) by Region (2013-2018)

Table United States Drug-Eluting Bioabsorbable Stents Sales Share by Region (2013-2018)

Figure United States Drug-Eluting Bioabsorbable Stents Sales Share by Region (2013-2018)

Figure United States Drug-Eluting Bioabsorbable Stents Sales Market Share by Region in 2017

Table United States Drug-Eluting Bioabsorbable Stents Revenue (Million USD) and Market Share by Region (2013-2018)

Table United States Drug-Eluting Bioabsorbable Stents Revenue Share by Region (2013-2018)

Figure United States Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region (2013-2018)

Figure United States Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region in 2017

Table United States Drug-Eluting Bioabsorbable Stents Price (USD/Unit) by Region (2013-2018)

Table United States Drug-Eluting Bioabsorbable Stents Sales (K Units) by Type (2013-2018)

Table United States Drug-Eluting Bioabsorbable Stents Sales Share by Type (2013-2018)

Figure United States Drug-Eluting Bioabsorbable Stents Sales Share by Type (2013-2018)

Figure United States Drug-Eluting Bioabsorbable Stents Sales Market Share by Type in 2017

Table United States Drug-Eluting Bioabsorbable Stents Revenue (Million USD) and Market Share by Type (2013-2018)

Table United States Drug-Eluting Bioabsorbable Stents Revenue Share by Type (2013-2018)

Figure Revenue Market Share of Drug-Eluting Bioabsorbable Stents by Type (2013-2018)

Figure Revenue Market Share of Drug-Eluting Bioabsorbable Stents by Type in 2017

Table United States Drug-Eluting Bioabsorbable Stents Price (USD/Unit) by Types (2013-2018)

Figure United States Drug-Eluting Bioabsorbable Stents Sales Growth Rate by Type (2013-2018)

Table United States Drug-Eluting Bioabsorbable Stents Sales (K Units) by Application (2013-2018)

Table United States Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2013-2018)

Figure United States Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2013-2018)

Figure United States Drug-Eluting Bioabsorbable Stents Sales Market Share by Application in 2017

Table United States Drug-Eluting Bioabsorbable Stents Sales Growth Rate by Application (2013-2018)

Figure United States Drug-Eluting Bioabsorbable Stents Sales Growth Rate by Application (2013-2018)

Table Medtronic Basic Information List

Table Medtronic Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Medtronic Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2013-2018)

Figure Medtronic Drug-Eluting Bioabsorbable Stents Sales Market Share in United States (2013-2018)

Figure Medtronic Drug-Eluting Bioabsorbable Stents Revenue Market Share in United States (2013-2018)

Table B.Braun Melsungen Basic Information List

Table B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2013-2018)

Figure B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Sales Market Share in United States (2013-2018)

Figure B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Revenue Market Share in United States (2013-2018)

Table Abbott Laboratories Basic Information List

Table Abbott Laboratories Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Abbott Laboratories Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2013-2018)

Figure Abbott Laboratories Drug-Eluting Bioabsorbable Stents Sales Market Share in United States (2013-2018)

Figure Abbott Laboratories Drug-Eluting Bioabsorbable Stents Revenue Market Share in United States (2013-2018)

Table Boston Scientific Corporation Basic Information List

Table Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2013-2018)

Figure Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales Market Share in United States (2013-2018)

Figure Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Revenue Market Share in United States (2013-2018)

Table Biosensors International Basic Information List

Table Biosensors International Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Biosensors International Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2013-2018)

Figure Biosensors International Drug-Eluting Bioabsorbable Stents Sales Market Share in United States (2013-2018)

Figure Biosensors International Drug-Eluting Bioabsorbable Stents Revenue Market Share in United States (2013-2018)

Table Terumo Corporation. Basic Information List

Table Terumo Corporation. Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Terumo Corporation. Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2013-2018)

Figure Terumo Corporation. Drug-Eluting Bioabsorbable Stents Sales Market Share in United States (2013-2018)

Figure Terumo Corporation. Drug-Eluting Bioabsorbable Stents Revenue Market Share in United States (2013-2018)

Table MicroPort Scientific Corporation Basic Information List

Table MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2013-2018)

Figure MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales Market Share in United States (2013-2018)

Figure MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Revenue Market Share in United States (2013-2018)

Table Alvimedica Basic Information List

Table Alvimedica Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Alvimedica Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2013-2018)

Figure Alvimedica Drug-Eluting Bioabsorbable Stents Sales Market Share in United States (2013-2018)

Figure Alvimedica Drug-Eluting Bioabsorbable Stents Revenue Market Share in United States (2013-2018)

Table Biotronik Basic Information List

Table Biotronik Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Biotronik Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2013-2018)

Figure Biotronik Drug-Eluting Bioabsorbable Stents Sales Market Share in United States (2013-2018)

Figure Biotronik Drug-Eluting Bioabsorbable Stents Revenue Market Share in United States (2013-2018)

Table Elixir Medical Corporation Basic Information List

Table Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2013-2018)

Figure Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Sales Market Share in United States (2013-2018)

Figure Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Revenue Market Share in United States (2013-2018)

Table Innovative Health Technologies Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Drug-Eluting Bioabsorbable Stents

Figure Manufacturing Process Analysis of Drug-Eluting Bioabsorbable Stents

Figure Drug-Eluting Bioabsorbable Stents Industrial Chain Analysis

Table Raw Materials Sources of Drug-Eluting Bioabsorbable Stents Major Players/Suppliers in 2017

Table Major Buyers of Drug-Eluting Bioabsorbable Stents

Table Distributors/Traders List

Figure United States Drug-Eluting Bioabsorbable Stents Sales Volume (K Units) and Growth Rate Forecast (2018-2025)

Figure United States Drug-Eluting Bioabsorbable Stents Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure United States Drug-Eluting Bioabsorbable Stents Price (USD/Unit) Trend Forecast (2018-2025)

Table United States Drug-Eluting Bioabsorbable Stents Sales Volume (K Units) Forecast by Type (2018-2025)

Figure United States Drug-Eluting Bioabsorbable Stents Sales Volume (K Units) Forecast by Type (2018-2025)

Figure United States Drug-Eluting Bioabsorbable Stents Sales Volume (K Units) Forecast by Type in 2025

Table United States Drug-Eluting Bioabsorbable Stents Sales Volume (K Units) Forecast by Application (2018-2025)

Figure United States Drug-Eluting Bioabsorbable Stents Sales Volume (K Units) Forecast by Application (2018-2025)

Figure United States Drug-Eluting Bioabsorbable Stents Sales Volume (K Units) Forecast by Application in 2025

Table United States Drug-Eluting Bioabsorbable Stents Sales Volume (K Units) Forecast by Region (2018-2025)

Table United States Drug-Eluting Bioabsorbable Stents Sales Volume Share Forecast by Region (2018-2025)

Figure United States Drug-Eluting Bioabsorbable Stents Sales Volume Share Forecast by Region (2018-2025)

Figure United States Drug-Eluting Bioabsorbable Stents Sales Volume Share Forecast by Region in 2025

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources